Zhao-Li Tan

445 total citations
17 papers, 186 citations indexed

About

Zhao-Li Tan is a scholar working on Oncology, Surgery and Cancer Research. According to data from OpenAlex, Zhao-Li Tan has authored 17 papers receiving a total of 186 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 4 papers in Surgery and 4 papers in Cancer Research. Recurrent topics in Zhao-Li Tan's work include Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Zhao-Li Tan is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Cancer Immunotherapy and Biomarkers (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). Zhao-Li Tan collaborates with scholars based in China, Czechia and Thailand. Zhao-Li Tan's co-authors include Chuanhua Zhao, Ru Jia, Youliang Wang, Rongrui Liu, Yun Zhang, Jianming Xu, Yunping Zhu, Lin Li, Shuji Ogino and Yang Jin and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Cancer Research and Science Advances.

In The Last Decade

Zhao-Li Tan

12 papers receiving 184 citations

Peers

Zhao-Li Tan
Riham Katkhuda United States
Denise Lau United States
Spencer H. Shao United States
Zhao-Li Tan
Citations per year, relative to Zhao-Li Tan Zhao-Li Tan (= 1×) peers Christoph Suppan

Countries citing papers authored by Zhao-Li Tan

Since Specialization
Citations

This map shows the geographic impact of Zhao-Li Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao-Li Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao-Li Tan more than expected).

Fields of papers citing papers by Zhao-Li Tan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhao-Li Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao-Li Tan. The network helps show where Zhao-Li Tan may publish in the future.

Co-authorship network of co-authors of Zhao-Li Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Zhao-Li Tan. A scholar is included among the top collaborators of Zhao-Li Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao-Li Tan. Zhao-Li Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Zhang, Yehao, et al.. (2025). Inflammation and platelet hyperresponsiveness in coronary artery disease and the influence of Talin-1/αIIbβ3-mediated bidirectional signaling pathway. Frontiers in Pharmacology. 16. 1535182–1535182. 1 indexed citations
3.
Feng, Dongdong, Dongxue Hu, Fangfang Xu, et al.. (2025). Expression of membrane-bound Interleukin-15 sustains the growth and survival of CAR-NK cells. International Immunopharmacology. 166. 115577–115577.
4.
Chen, Shiyun, Zhao-Li Tan, Yanli Lin, et al.. (2025). miR-196b strictly regulates and reliably predicts the response to cetuximab in colorectal cancer. Cellular & Molecular Biology Letters. 30(1). 64–64.
5.
Zhang, Xin, Yingfeng Cai, Jianpeng Zhou, et al.. (2025). Heel kicking exercise rapidly improves pain and function in patients with acute lateral ankle sprain: a randomized controlled trial. BMC Musculoskeletal Disorders. 26(1). 666–666.
7.
Chen, Shiyun, Zhao-Li Tan, Yanli Lin, et al.. (2024). Single‐cell sequencing analysis reveals cetuximab resistance mechanism and salvage strategy in colorectal cancer. Clinical and Translational Medicine. 15(1). e70151–e70151. 2 indexed citations
9.
Han, Lu, et al.. (2023). Hyperprogressive disease during PD-1 blockade in patients with advanced pancreatic cancer. Human Vaccines & Immunotherapeutics. 19(2). 4 indexed citations
10.
Chen, Shiyun, Shiyuan Guo, Miaomiao Gou, et al.. (2022). A composite indicator of derived neutrophil–lymphocyte ratio and lactate dehydrogenase correlates with outcomes in pancreatic carcinoma patients treated with PD-1 inhibitors. Frontiers in Oncology. 12. 951985–951985. 7 indexed citations
11.
Chang, Liisa, Chuanhua Zhao, Ru Jia, et al.. (2021). Peripheral blood T-cell receptor repertoire as a predictor of clinical outcomes in gastrointestinal cancer patients treated with PD-1 inhibitor. Clinical & Translational Oncology. 23(8). 1646–1656. 13 indexed citations
12.
Tan, Zhao-Li, Chunyan Yue, Chuanhua Zhao, et al.. (2021). Assessment of PD-L1 Expression on Circulating Tumor Cells for Predicting Clinical Outcomes in Patients with Cancer Receiving PD-1/PD-L1 Blockade Therapies. The Oncologist. 26(12). e2227–e2238. 31 indexed citations
13.
Tan, Zhao-Li, Yong Shao, Peng Du, et al.. (2020). PRSS contributes to cetuximab resistance in colorectal cancer. Science Advances. 6(1). eaax5576–eaax5576. 32 indexed citations
14.
Li, Zongcheng, Yuling Chen, Wu Ren, et al.. (2019). Transcriptome Alterations in Liver Metastases of Colorectal Cancer After Acquired Resistance to Cetuximab. Cancer Genomics & Proteomics. 16(3). 207–219. 9 indexed citations
15.
Xu, Jian-Ming, Yan Wang, Youliang Wang, et al.. (2017). PIK3CA Mutations Contribute to Acquired Cetuximab Resistance in Patients with Metastatic Colorectal Cancer. Clinical Cancer Research. 23(16). 4602–4616. 64 indexed citations
16.
Tan, Zhao-Li, et al.. (2016). Lineage tracing reveals conversion of liver sinusoidal endothelial cells into hepatocytes. Development Growth & Differentiation. 58(7). 620–631. 3 indexed citations
17.
Wu, Yan, Julia Li Zhong, Ning Hou, et al.. (2016). MicroRNA Let‐7b inhibits keratinocyte migration in cutaneous wound healing by targeting IGF2BP2. Experimental Dermatology. 26(2). 116–123. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026